Polymyalgia rheumatica and Memory loss

Summary:

Memory loss is found among people with Polymyalgia rheumatica, especially for people who are female, 60+ old.

The study analyzes which people have Memory loss with Polymyalgia rheumatica. It is created by eHealthMe based on reports of 94 people who have Polymyalgia rheumatica from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Polymyalgia rheumatica?

Polymyalgia rheumatica (pain in many muscles) is found to be associated with 381 drugs and 554 conditions by eHealthMe. Check the latest studies of Polymyalgia rheumatica.

What is Memory loss?

Memory loss is found to be associated with 2,728 drugs and 4,375 conditions by eHealthMe. Check the latest studies of Memory loss.



On Jul, 17, 2026

94 people who have Polymyalgia Rheumatica and Memory Loss are studied.

Would you have Memory loss when you have Polymyalgia rheumatica?

Gender of people who have Polymyalgia Rheumatica and experienced Memory Loss *:

  • female: 70.59 %
  • male: 29.41 %

Age of people who have Polymyalgia Rheumatica and experienced Memory Loss *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 1.52 %
  • 40-49: 0.0 %
  • 50-59: 12.12 %
  • 60+: 86.36 %

Common co-existing conditions for these people *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 25 people, 26.60%
  2. High Blood Cholesterol: 13 people, 13.83%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 12.77%
  4. Pain: 11 people, 11.70%
  5. Insomnia (sleeplessness): 10 people, 10.64%
  6. Blood Pressure Abnormal: 9 people, 9.57%
  7. High Blood Pressure: 9 people, 9.57%
  8. Immune System Disorder: 6 people, 6.38%
  9. Osteoporosis (bones weak and more likely to break): 5 people, 5.32%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 4.26%

Common drugs taken by these people *:

  1. Prednisone: 25 people, 26.60%
  2. Actemra: 23 people, 24.47%
  3. Xeljanz Xr: 14 people, 14.89%
  4. Zetia: 10 people, 10.64%
  5. Pantoprazole: 10 people, 10.64%
  6. Baby Aspirin: 7 people, 7.45%
  7. Carvedilol: 7 people, 7.45%
  8. Plaquenil: 7 people, 7.45%
  9. Dapsone: 6 people, 6.38%
  10. Valium: 6 people, 6.38%

Common symptoms for these people *:

  1. Pain: 29 people, 30.85%
  2. Fatigue (feeling of tiredness): 28 people, 29.79%
  3. Visual Impairment: 25 people, 26.60%
  4. Weakness: 25 people, 26.60%
  5. Gait Disturbance: 19 people, 20.21%
  6. Depression: 17 people, 18.09%
  7. Anaemia (lack of blood): 17 people, 18.09%
  8. Confusional State: 17 people, 18.09%
  9. Pain In Extremity: 16 people, 17.02%
  10. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 16 people, 17.02%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Memory loss?

- Check whether Memory loss is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Memory loss:

All the conditions that are associated with Memory loss:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Memory loss and Polymyalgia rheumatica, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: